Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1250 of 2026 entries
View as:

Study of the Treatment of Algerian Patients With Early Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT02008266 Org: User:
Start: 09/30/11 End: 12/31/12 Due: 12/31/13

Observational Study to Evaluate Disease Course and Outcomes in Patients Treated With Esbriet (Pirfenidone) for Idiopathic Pulmonary Fibrosis (IPF) in Canada

Phase: N/A Priority: Normal
NCT ID: NCT02552849 Org: User:
Start: 04/25/13 End: 08/15/17 Due: 08/15/18

A Study of the Efficacy and Safety of MetMAb Combined With Tarceva in Patients With Met-Positive Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02031744 Org: User:
Start: 01/22/14 End: 01/06/16 Due: 01/06/17

A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03038100 Org: User:
Start: 03/08/17 End: 08/12/22 Due: 08/12/23

A Study Evaluating the Safety and Efficacy of Multiple Treatments in Participants With Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT05583617 Org: User:
Start: 11/14/23 End: 05/31/27 Due: 05/31/28

A Study of Pertuzumab in Participants With Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02491892 Org: User:
Start: 02/28/03 End: 04/30/05 Due: 04/30/06

A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia

Phase: N/A Priority: Normal
NCT ID: NCT04320615 Org: User:
Start: 04/03/20 End: 07/28/20 Due: 07/28/21

A Single Dose Study of Radiolabeled RO4602522 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01631422 Org: User:
Start: 06/30/12 End: 06/30/12 Due: 06/30/13

A Study of Pegasys (Peginterferon Alfa-2a) Administered Alone or in Combination With Copegus (Ribavirin) in Patients With Chronic Hepatitis C Who Have Participated in Previous Pegasys Trials

Phase: N/A Priority: Normal
NCT ID: NCT01853254 Org: User:
Start: 09/30/03 End: 09/30/11 Due: 09/30/12

An Observational Study of BRAF Inhibitors Effectiveness in Patients With Newly Diagnosed Metastatic Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT02143999 Org: User:
Start: 06/27/14 End: 12/30/16 Due: 12/30/17

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01437657 Org: User:
Start: 10/31/11 End: 09/30/13 Due: 09/30/14

Efficacy and Safety of Trastuzumab Emtansine in Chinese Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced or Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03084939 Org: User:
Start: 04/24/17 End: 03/14/23 Due: 03/14/24

A Study Comparing the Efficacy and Safety of Vanucizumab and FOLFOX With Bevacizumab and FOLFOX in Participants With Untreated Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02141295 Org: User:
Start: 06/30/14 End: 02/01/17 Due: 02/01/18

A Study of Atezolizumab in Combination With Bevacizumab Versus Sunitinib in Participants With Untreated Advanced Renal Cell Carcinoma (RCC)

Phase: N/A Priority: Normal
NCT ID: NCT02420821 Org: User:
Start: 05/20/15 End: 12/13/21 Due: 12/13/22

A Study to Evaluate Safety and Efficacy of Ocrelizumab in Comparison With Fingolimod in Children and Adolescents With Relapsing-Remitting Multiple Sclerosis (RRMS)

Phase: N/A Priority: Normal
NCT ID: NCT05123703 Org: User:
Start: 02/04/22 End: 09/17/29 Due: 09/17/30

A Study of Tocilizumab (RoActemra/Actemra) in Patients With Ankylosing Spondylitis Who Have Had an Inadequate Response to Previous Tumor Necrosis Factor (TNF) Antagonist Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01209689 Org: User:
Start: 10/31/10 End: 12/31/11 Due: 12/31/12

A Study to Evaluate the Effect of the Combination of Pertuzumab With Carboplatin-Based Standard Chemotherapy in Patients With Recurrent Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02004093 Org: User:
Start: 12/31/05 End: 09/30/08 Due: 09/30/09

Evaluation of the Cobas® 4800 HPV Test for the Detection of High-grade Cervical Disease

Phase: N/A Priority: Normal
NCT ID: NCT00709891 Org: User:
Start: 05/31/08 End: 06/30/13 Due: 06/30/14

A Study of Decreased Dose Frequency in Participants With Systemic Juvenile Arthritis Who Experience Laboratory Abnormalities During Treatment With RoActemra/Actemra (Tocilizumab)

Phase: N/A Priority: Normal
NCT ID: NCT01734382 Org: User:
Start: 06/10/13 End: 10/09/19 Due: 10/09/20

A Long-Term Extension Study of WA22763 and NA25220 of Subcutaneous RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01772316 Org: User:
Start: 12/31/12 End: 05/31/15 Due: 05/31/16

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg-Positive or HBeAg-Negative Chronic Hepatitis B

Phase: N/A Priority: Normal
NCT ID: NCT01734018 Org: User:
Start: 08/31/11 End: 08/31/12 Due: 08/31/13

A Relative Bioavailability Study of Valcyte (Valganciclovir) in Lung Transplant Recipients With or Without Cystic Fibrosis.

Phase: N/A Priority: Normal
NCT ID: NCT00377741 Org: User:
Start: 12/31/04 End: 06/30/06 Due: 06/30/07

A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Sulfonylurea Alone or Sulfonylurea Plus Metformin Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01691989 Org: User:
Start: 12/31/12 End: 09/30/13 Due: 09/30/14

A Study of Escalating Doses of DCDS0780A in Participants With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT02453087 Org: User:
Start: 08/04/15 End: 07/12/19 Due: 07/12/20

A Study of Vemurafenib in Previously Treated Patients With Metastatic Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00949702 Org: User:
Start: 09/30/09 End: 06/03/14 Due: 06/03/15